Could a custom vaccine teach the immune system to stop attacking the pancreas?
NCT ID NCT04590872
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This early-phase study tests a new vaccine made from a person's own immune cells and a small piece of insulin protein. The goal is to see if it is safe and possible to teach the immune system to stop destroying the pancreas cells that make insulin. Six adults with type 1 diabetes who use insulin will receive the vaccine and be followed for about two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.